Oro-Anal Transit Time and Colon Manometry: Predictability and Outcomes in Children With Functional Constipation.
ace
colonic manometry
constipation
oro-anal transit time
sitzmarks
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
accepted:
01
11
2023
medline:
11
12
2023
pubmed:
11
12
2023
entrez:
11
12
2023
Statut:
epublish
Résumé
The primary objective of the study was to evaluate the correlation of oro-anal transit time (OTT) using SITZMARKS® (Konsyl Pharmaceuticals Inc., Easton, MD, USA) with colonic manometry (CM) in children with chronic idiopathic constipation (CIC). The secondary objective was to determine the clinical utility of these studies in directing treatment strategies. A retrospective chart review of 44 children with CIC was evaluated with both OTT and CM. The median follow-up was one year (0.3 to 7). Seventeen children had normal OTT, and 27 had abnormal OTT (slow-transit constipation (STC)). There was no statistical difference between the percentage of children with abnormal CM (13) test results categorized by OTT (23.5% normal OTT vs. 33% abnormal OTT, p = 0.73). A change in therapy was accepted by all 13 children with abnormal CM, but only 26/31 (84%) of the children had normal CM. The CM test results prompted acceptance of treatment change (appendicectomy or medication escalation) in 89% of children. Overall, 31/44 (70%) of children undergoing CM testing had improvement in clinical symptoms. More children with abnormal CM testing improved vs. normal CM but did not reach significance (85% vs. 65%, p = 0.28). Contrary to previous studies, OTT results did not predict the presence of colonic dysmotility based on colon motility testing. Colonic manometry testing resulted in the acceptance of a change in therapy in approximately 90% of children. More children with colonic dysmotility improved versus those with normal CM studies. Other interventions beyond stimulant laxatives should be considered in children with refractory constipation.
Identifiants
pubmed: 38073958
doi: 10.7759/cureus.48397
pmc: PMC10700092
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e48397Informations de copyright
Copyright © 2023, Shaukat et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Pediatr Gastroenterol Nutr. 2011 Jan;52(1):47-54
pubmed: 20890220
Gut. 1993 Mar;34(3):402-8
pubmed: 8472991
J Pediatr Surg. 2016 Oct;51(10):1607-12
pubmed: 27329390
J Pediatr Gastroenterol Nutr. 2014 Feb;58(2):258-74
pubmed: 24345831
J Pediatr Gastroenterol Nutr. 2013 Nov;57(5):598-602
pubmed: 24177783
Int J Colorectal Dis. 2013 Dec;28(12):1721-4
pubmed: 23887805
World J Gastroenterol. 2005 May 14;11(18):2691-6
pubmed: 15884105
Gastroenterology. 2016 Feb 15;:
pubmed: 27144632
J Pediatr. 2009 Feb;154(2):258-62
pubmed: 18822430
Pediatr Gastroenterol Hepatol Nutr. 2020 Mar;23(2):137-145
pubmed: 32206626
Rev Esp Med Nucl Imagen Mol. 2017 May - Jun;36(3):146-151
pubmed: 27956094
Semin Nucl Med. 2012 Mar;42(2):113-23
pubmed: 22293166
Neurogastroenterol Motil. 2017 Jan;29(1):
pubmed: 27723185
Am J Gastroenterol. 2003 May;98(5):1052-7
pubmed: 12809827
Pediatr Surg Int. 2009 Jul;25(7):559-72
pubmed: 19488763
Neurogastroenterol Motil. 2017 Oct;29(10):1-9
pubmed: 28524640
Neurogastroenterol Motil. 2016 Nov;28(11):1747-1755
pubmed: 27335210
Neurogastroenterol Motil. 2013 Jan;25(1):70-8.e8-9
pubmed: 23030503
AJR Am J Roentgenol. 2007 Aug;189(2):W56-9
pubmed: 17646438
Pediatrics. 2010 Jul;126(1):e156-62
pubmed: 20530072
Neurogastroenterol Motil. 2013 Feb;25(2):140-e81
pubmed: 23035840
J Pediatr Gastroenterol Nutr. 2012 Feb;54(2):258-62
pubmed: 21734599
Neurogastroenterol Motil. 2017 Jul;29(7):
pubmed: 28317231
Neurogastroenterol Motil. 2016 May;28(5):743-57
pubmed: 26867952